Latest Regulatory News

Winchester Energy Limited’s shares have been suspended from ASX trading due to a failure to meet director requirements under the Corporations Act, raising questions about its governance and future compliance.

Macarthur Minerals has clarified the timing of its entitlement offer, confirming the securities issue date as 7 August 2025 with ASX quotation expected the following day. The company also reaffirmed its substantial iron ore resources at Lake Giles, maintaining investor confidence ahead of the capital raise.

Ardea Resources is progressing its Kalgoorlie Nickel Project with a fully funded Definitive Feasibility Study by Sumitomo Metal Mining and Mitsubishi Corporation, aiming to deliver a long-life, low-cost nickel-cobalt supply from Australia’s largest resource.

Rimfire Pacific Mining Limited has had its trading suspension lifted immediately following the release of its capital raising results, signaling renewed market activity.

Perpetual Resources Limited has requested a voluntary suspension of its shares on the ASX, pending important announcements related to exploration activities and a regulatory query. The suspension is expected to last until the market opens on July 24, 2025.

Lachlan Star Limited reports promising maiden drilling results at its Killaloe Gold Project in Western Australia and initiates copper-gold drilling at North Cobar, NSW, while securing permits for further Basin Creek exploration.

Astute Metals NL sharpens its focus on Nevada’s rich mineral landscape, unveiling fresh high-grade gold targets at Needles and reaffirming lithium potential at Red Mountain amid leadership changes.

Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

Bowen Coking Coal’s initial attempt to defer state royalty payments has been declined by the Queensland Revenue Office, prompting plans for a revised proposal amid ongoing debt restructuring efforts.

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.

Emmerson Resources’ latest Scoping Study confirms the White Devil Gold Project as a Major Mine, projecting robust financial returns and a seven-year mine life. With feasibility studies underway and a strategic JV structure, the project is poised for development in the Northern Territory.